Vivimed Labs Ltd.
| BSE: 532660 | Sector: Health care |
| NSE: VIVIMEDLAB | ISIN Code: INE526G01021 |
| BSE 00:00 | 18 May | 14.05 |
-0.55 (-3.77%) |
OPEN
14.30 |
HIGH
14.90 |
LOW
13.85 |
| NSE 00:00 | 18 May | 14.20 |
-0.40 (-2.74%) |
OPEN
14.80 |
HIGH
14.90 |
LOW
14.00 |
| OPEN | 14.30 |
| PREVIOUS CLOSE | 14.60 |
| VOLUME | 46001 |
| 52-Week high | 34.20 |
| 52-Week low | 13.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 116 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Vivimed Labs Ltd.
Vivimed Labs Ltd is engaged in manufacturing of Specialty Chemicals (mainly used in Personal Care and Cosmetic Industry) Pharmaceuticals API's and Formulations. The company has strong presence in the areas of Health & Personal Care Contract Research and Manufacturing. The company has four subsidiary companies namely Creative Health Care Pvt Ltd Vivimed Holdings Ltd (Hong Kong) Vivimed Labs Europe ...> More
Vivimed Labs Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
116 | |
| EPS - TTM | () |
[*S] | - |
| P/E Ratio | (X) | [*S] | - |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 20.00 | |
| Latest Dividend Date | 19 Sep 2018 | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 55.59 |
| P/B Ratio | () |
[*S] | 0.25 |
Announcement
-
Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations 2015)
-
Vivimed Labs Limited - Disclosure under SEBI Takeover Regulations
-
Disclosure Under Regulation 31(1) & 31(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers)
-
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
Vivimed Labs Ltd - Financial Results
Particulars ( cr) |
Dec 2021 | Dec 2020 | % Chg |
| Net Sales | 56.52 | 277.94 | -79.66 |
| Other Income | -0.36 | 4.34 | -108.29 |
| Total Income | 56.16 | 282.29 | -80.11 |
| Total Expenses | 63.81 | 299.8 | -78.72 |
| Operating Profit | -7.65 | -17.52 | 56.34 |
| Net Profit | -23.68 | -49.55 | 52.21 |
| Equity Capital | 16.58 | 16.58 | - |
Vivimed Labs Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Bharat Immunolog | 29.70 | 1.71 | 128.24 |
| Everest Organics | 160.20 | -2.50 | 128.16 |
| Samrat Pharma | 407.45 | 3.81 | 125.90 |
| Vivimed Labs. | 14.05 | -3.77 | 116.47 |
| Natural Caps. PP | 370.10 | -0.44 | 115.47 |
| Aarey Drugs | 41.65 | -1.19 | 105.71 |
| Biofil Chemicals | 58.55 | 0.43 | 95.26 |
Vivimed Labs Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherVivimed Labs Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | 1.81% | 3.27% | 0.22% | 0.45% |
| 1 Month | -15.51% | -14.71% | -5.17% | -5.43% |
| 3 Month | -26.25% | -25.46% | -6.27% | -6.00% |
| 6 Month | -22.59% | -21.76% | -9.10% | -8.58% |
| 1 Year | -53.32% | -52.43% | 8.00% | 7.49% |
| 3 Year | -30.10% | -28.82% | 42.91% | 42.37% |
Vivimed Labs Ltd - STOCK STRENGTH
| Today's Low/High | 13.85 |
|
14.90 |
| Week Low/High | 13.00 |
|
14.90 |
| Month Low/High | 13.00 |
|
17.00 |
| YEAR Low/High | 13.00 |
|
34.00 |
| All TIME Low/High | 6.44 |
|
153.00 |
Quick Links for Vivimed Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
